What is the combined effect of insomnia and OSA on all-cause mortality and the occurrence of hypertension, cardiovascular disease, and diabetes?
Your search for comorbidities returned 12 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
There is a substantial burden, unawareness, and undertreatment of several systemic comorbidities—particularly cardiovascular and psychiatric—in patients with HS.
The prescribing to patients with hypertension with or without comorbidities of optimized drug combinations with complementary modes of action for the lowering of blood pressure was not found to be widely adopted.
Abnormal respiratory vital signs coupled with a set of ECG findings were found to predict early deterioration in patients with COVID-19.
Cannabis users were found to have higher rates of acute myocardial infarction (AMI) and recurrent AMI compared with nonusers.
Hyperuricemia may represent a risk factor for stroke, and severe hypertension may mediate this association.
The American Heart Association (AHA) released a scientific statement summarizing the effects of obstructive sleep apnea on the cardiovascular health of children and adolescents, as well as the current best practices for diagnosis and evaluation of CVD-related complications of OSA.
The AHA outlines screening, diagnosis, and treatment recommendations for obstructive sleep apnea and CV complications tied to the sleep disorder.
Patients with blood pressure levels of >150/95 mm Hg may benefit from initial combination therapy of losartan and hydrochlorothiazide.